What Should Investors Buy Heading Into April 2026?

VXUS returned 27% over the past year and is recommended as a way to add international exposure amid valuation concerns in U.S. stocks (S&P 500 total return 289% over the past decade as of Mar 13). The ETF holds 8,703 non-U.S. stocks with Japan, U.K., China, Canada and Taiwan making up 47% and emerging markets 26%; sector weights: 15.6% technology vs S&P 32.4% and 23% financials. Expense ratio is 0.05% ($5/yr on $10,000); the author suggests buying enough to create roughly a 4% portfolio position to improve geographic diversification.

Analysis

Capital is starting to sniff for efficiency outside the U.S., but the real tactical lever is sector- and country-level concentration within that international allocation. A modest reallocation (roughly 2–4% of global equity AUM) away from U.S. mega-cap tech into developed ex‑US and EM can mechanically peel 150–300bp off the technology sector’s share of global cap-weighted indices, improving cyclicals and financials’ relative forward earnings yield within 3–12 months.

Second‑order winners include European banks and commodity exporters: higher relative rates or a weaker dollar would re-rate their net interest margins and local-currency revenues; losers would be global software and AI infrastructure names whose multiples rely on dollar‑based revenue growth. Key catalysts to watch over the next 90–180 days are USD direction, China policy surprises (both fiscal/credit loosening and regulatory), and the cadence of AI earnings — any of which can flip flows back to the U.S. within weeks.

The consensus “buy international ETF” trade understates concentration risk: large non‑U.S. caps (TSMC/Nestlé equivalents) can recreate single‑name risk outside the U.S., so naive VXUS-sized allocations give illusion of diversification. Tactical implementation should therefore prefer active or factor‑tilted exposures (value, cyclicals, financials) or pair trades that short U.S. tech concentration rather than one-way EM/DM beta buys.

Key Decisions for Investors

• Pair trade (3–9 months): Short NVDA via a 3-month put-heavy call spread (buy 1 10% OTM put, sell 1 20% OTM put) sized to cap portfolio risk at 0.5%; simultaneously go long INTC with a 9–12 month call purchase (or 1.5–2% notional long stock). R/R: asymmetric — limited short premium vs larger multi‑month upside if semiconductor cycle normalizes away from premium AI pricing; stop-loss: NVDA up 20% from entry.
• Thematic overweight (6–18 months): Increase exposure to developed ex‑US value/cyclicals (EFA or a value-tilted EAFE fund, or selective VXUS active managers) by 3–5% funded by trimming NDAQ/QQQ exposure by the same amount. R/R: 15–25% relative upside if multiple compression continues in US tech; downside: 8–12% absolute draw if U.S. growth and AI earnings re-accelerate.
• Idiosyncratic long (6–12 months): Add a modest long position in NFLX (1–2% portfolio) or buy 9–12 month calls sized similarly — conviction driven by positive sentiment tilt and durable cash flow optionality from advertising/price levers. R/R: upside >30% on upside subscriber/monetization beats; cut to breakeven or smaller size if engagement metrics drop >10% sequentially.
• Hedge/insurance (0–3 months): Buy 3‑month NDAQ index put spread (1–3% OTM buy / 4–6% OTM sell) sized so premium <0.5% of portfolio to protect against a rapid tech‑flow reversal. R/R: limited cost for 4–10% downside protection across concentrated tech exposures; unwind if NDAQ implied vol collapses by >40% or macro CPI surprises are clearly benign.